Fluorescence in situ hybridization analysis with a tissue microarray: 'FISH and chips' analysis of pathology archives

Pathology International

Volumn 60, Issue 8, 2010, Pages 543-550

  Sugimura, Haruhiko ^a   Mori, Hiroki ^a   Nagura, Kiyoko ^a   Kiyose, Shin Ichiro ^a   Hong, Tao ^a   Isozaki, Masaru ^b   Igarashi, Hisaki ^a   Shinmura, Kazuya ^a   Hasegawa, Akio ^b   Kitayama, Yasuhiko ^c   Tanioka, Fumihiko ^d  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Odawara Municipal Hospital   (Japan)

^c International University of Health and Welfare Mita Hospital   (Japan)

^d Iwata City Hospital   (Japan)

Author keywords

copy number alteration; fluorescence in situ hybridization (FISH); formalin fixed paraffin embedded (FFPE) tissue; pathology archives; tissue microarray (TMA)

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRANSCRIPTION FACTOR GATA 6;

BACTERIAL ARTIFICIAL CHROMOSOME; CARCINOGENESIS; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DIAGNOSTIC ACCURACY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; MEDICAL ETHICS; MEDICAL PRACTICE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOLID TUMOR; TISSUE MICROARRAY; TUMOR CELL; GENETICS; HUMAN GENOME; NEOPLASM;

CHROMOSOMES, ARTIFICIAL, BACTERIAL; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 77954494409     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2010.02561.x     Document Type: Review

References (70)

1. Weinberg RA. Biology of Cancer.
2. Bialy H. Oncogenes, Aneuploidy, and AIDS: A Scientific Life and Times of Peter H. Duesberg.
3. Beroukhim R, Merml CH, Porter D et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010 463 : 899 905.
4. de Ravel TJ, Devriendt K, Fryns JP, Vermeesch JR. What's new in karyotyping? The move towards array comparative genomic hybridisation (CGH). Eur J Pediatr 2007 166 : 637 643.
5. Yoshimoto M, Cutz JC, Nuin PA et al. Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias. Cancer Genet Cytogenet 2006 169 : 128 137.
6. Frohling S, Dohner H. Chromosomal abnormalities in cancer. N Engl J Med 2008 359 : 722 734.
7. Soda M, Choi YL, Enomoto M et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007 448 : 561 566.
8. Velculescu VE. Defining the blueprint of the cancer genome. Carcinogenesis 2008 29 : 1087 1091.
9. Wood LD, Parsons DW, Jones S et al. The genomic landscapes of human breast and colorectal cancers. Science 2007 318 : 1108 1113.
10. Weir BA, Woo MS, Getz G et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007 450 : 893 898.
11. Kubo T, Kuroda Y, Shimizu H et al. Resequencing and Copy Number Analysis of the Human Tyrosine Kinase Gene Family in Poorly Differentiated Gastric Cancer. Carcinogenesis 2009 30 : 1857 1864.
12. Campbell PJ, Stephens PJ, Pleasance ED et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 2008 40 : 722 729.
13. Watters AD, Ballantyne SA, Going JJ, Grigor KM, Bartlett JM. Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder. BJU Int 2000 85 : 42 7.
14. Skacel M, Ormsby AH, Pettay JD et al. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: A differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray. Hum Pathol 2001 32 : 1392 1397.
15. Bayani J, Squire JA. Application and interpretation of FISH in biomarker studies. Cancer Lett 2007 249 : 97 109.
16. Tibiletti MG, Bernasconi B, Dionigi A, Riva C. The applications of FISH in tumor pathology. Adv Clin Path 1999 3 : 111 118.
17. Giltnane JM, Murren JR, Rimm DL, King BL. AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray. Histopathology 2006 49 : 161 169.
18. Lee CH, Huntsman DG, Cheang MC et al. Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma. Int J Gynecol Pathol 2005 24 : 147 152.
19. Hicks DG, Tubbs RR. Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: A technical review with interpretive guidelines. Hum Pathol 2005 36 : 250 261.
20. Iwasaki H, Nabeshima K, Nishio J et al. Pathology of soft-tissue tumors: Daily diagnosis, molecular cytogenetics and experimental approach. Pathol Int 2009 59 : 501 521.
21. Schraml P, Kononen J, Bubendorf L et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 1999 5 : 1966 1975.
22. Al Kuraya K, Simon R, Sauter G. Tissue microarrays for high-throughput molecular pathology. Ann Saudi Med 2004 24 : 169 174.
23. Drev P, Grazio SF, Bracko M. Tissue microarrays for routine diagnostic assessment of HER2 status in breast carcinoma. Appl Immunohistochem Mol Morphol 2008 16 : 179 184.
24. Dhir R. Tissue microarrays: An overview. Methods Mol Biol 2008 441 : 91 103.
25. Toncheva D, Petrova D, Tzenova V et al. Tissue microarray analysis of cyclin D1 gene amplification and gain in colorectal carcinomas. Tumour Biol 2004 25 : 157 160.
26. Koynova DK, Tsenova VS, Jankova RS, Gurov PB, Toncheva DI. Tissue microarray analysis of EGFR and HER2 oncogene copy number alterations in squamous cell carcinoma of the larynx. J Cancer Res Clin Oncol 2005 131 : 199 203.
27. Okon K, Sinczak-Kuta A, Klimkowska A et al. Tissue microarray FISH applied to colorectal carcinomas with various microsatellite status. Pol J Pathol 2006 57 : 99 103.
28. Brown LA, Huntsman D. Fluorescent in situ hybridization on tissue microarrays: Challenges and solutions. J Mol Histol 2007 38 : 151 157.
29. von Schalburg KR, Rise ML, Cooper GA et al. Fish and chips: Various methodologies demonstrate utility of a 16,006-gene salmonid microarray. BMC Genomics 2005 6 : 126.
30. Sugimura H. Detection of chromosome changes in pathology archives: An application of microwave-assisted fluorescence in situ hybridization to human carcinogenesis studies. Carcinogenesis 2008 29 : 681 687.
31. Meaburn KJ, Gudla PR, Khan S, Lockett SJ, Misteli T. Disease-specific gene repositioning in breast cancer. J Cell Biol 2009 187 : 801 812.
32. Gunter C. Reliable repositioning in cancer. Nat Rev Cancer 2010 10 : 84 85.
33. Holst F, Stahl PR, Ruiz C et al. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 2007 39 : 655 660.
34. Brown LA, Hoog J, Chin SF et al. ESR1 gene amplification in breast cancer: A common phenomenon? Nat Genet 2008 40 : 806 807, author reply 10-2.
35. Horlings HM, Bergamaschi A, Nordgard SH et al. ESR1 gene amplification in breast cancer: A common phenomenon? Nat Genet 2008 40 : 807 808, reply 10-2.
36. Wolff AC, Hammond ME, Schwartz JN et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007 25 : 118 145.
37. Kasami M, Uematsu T, Honda M et al. Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy. Breast 2008 17 : 523 527.
38. Sano T, Kitayama Y, Igarashi H et al. Chromosomal numerical abnormalities in early stage lung adenocarcinoma. Pathol Int 2006 56 : 117 125.
39. Kitayama Y, Igarashi H, Watanabe F, Maruyama Y, Kanamori M, Sugimura H. Nonrandom chromosomal numerical abnormality predicting prognosis of gastric cancer: A retrospective study of 51 cases using pathology archives. Lab Invest 2003 83 : 1311 1320.
40. O'Grady A, Flahavan CM, Kay EW, Barrett HL, Leader MB. HER-2 analysis in tissue microarrays of archival human breast cancer: Comparison of immunohistochemistry and fluorescence in situ hybridization. Appl Immunohistochem Mol Morphol 2003 11 : 177 182.
41. Morita Y, Ikegami K, Goto-Inoue N et al. Imaging mass spectrometry of gastric carcinoma in formalin-fixed paraffin-embedded tissue microarray. Cancer Science 2010 101 : 267 273.
42. Shapiro HT. Research involving human biologicalmaterials: Ethical issues and policy guidance. Commission NBA ed. Vol. 1. Rockville 1999 1 138.
43. WHO. World Health Organization, Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Services. WHO/HGN/GL/ETH/98.1. ed, 1998.
44. Wolf S. The American point of view regarding personal information protection [homepage on the Internet]: Japanese Ministry of Health, Welfare, and Labor I, 47-51. 2000 cited 7 June 2010) Series Title. Available from: http://www.mc.pref.osaka.jp/ocr/ocr-hcr/registry/security/report/wolff.pdf.
45. Ornes S. What happens to a donated tumor? CR 2009 36 45.
46. Zhou X, Rao NP, Cole SW, Mok SC, Chen Z, Wong DT. Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays. Cancer Genet Cytogenet 2005 159 : 53 7.
47. Kallioniemi A. CGH microarrays and cancer. Curr Opin Biotechnol 2008 19 : 36 40.
48. Bejjani BA, Shaffer LG. Clinical utility of contemporary molecular cytogenetics. Annu Rev Genomics Hum Genet 2008 9 : 71 86.
49. Inazawa J, Inoue J, Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 2004 95 : 559 563.
50. Gouas L, Goumy C, Veronese L, Tchirkov A, Vago P. Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities. Pathol Biol (Paris) 2008 56 : 345 353.
51. Gunn SR, Robetorye RS, Mohammed MS. Comparative genomic hybridization arrays in clinical pathology: Progress and challenges. Mol Diagn Ther 2007 11 : 73 7.
52. Callagy G, Jackson L, Caldas C. Comparative genomic hybridization using DNA from laser capture microdissected tissue. Methods Mol Biol 2005 293 : 39 55.
53. Ooi A, Zen Y, Ninomiya I et al. Gene Amplification of ERBB2 and EGFR in Adenocarcinoma in situ and Intramucosal Adenocarcinoma of Barrett's Esophagus. Pathol Int 2010 60 : 466 471.
54. Midorikawa Y, Yamamoto S, Ishikawa S et al. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene 2006 25 : 5581 5590.
55. Shinmura K, Kageyama S, Tao H et al. EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas. Lung Cancer 2008 61 : 163 169.
56. Pleasance ED, Stephens PJ, O'Meara S et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463 : 184 190.
57. Shinmura K, Kageyama S, Igarashi H et al. EML4-ALK fusion transcripts in immunohistochemically ALK-positive non-small cell lung canrcinomas. Exp Ther Med 2010 1 : 271 275.
58. Lo KC, Bailey D, Burkhardt T, Gardina P, Turpaz Y, Cowell JK. Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization. Genes Chromosomes Cancer 2008 47 : 221 237.
59. Coe BP, Macaulay C, Lam WL, Ylstra B, Carvalho B, Meijer GA. Comment re: A comparison of DNA copy number profiling platforms. Cancer Res 2008 68 : 4010, author reply 10.
60. Greshock J, Feng B, Nogueira C et al. A comparison of DNA copy number profiling platforms. Cancer Res 2007 67 : 10173 10180.
61. Ng G, Huang J, Roberts I, Coleman N. Defining ploidy-specific thresholds in array comparative genomic hybridization to improve the sensitivity of detection of single copy alterations in cell lines. J Mol Diagn 2006 8 : 449 458.
62. Suzuki M, Nagura K, Igarashi H et al. Copy number estimation algorithms and fluorescence in situ hybridization to describe copy number alterations in human tumors. Pathol Int 2009 59 : 218 228.
63. Yoshida H, Nagao K, Ito H, Yamamoto K, Ushigome S. Chromosomal translocations in human soft tissue sarcomas by interphase fluorescence in situ hybridization. Pathol Int 1997 47 : 222 229.
64. Ten Heuvel SE, Hoekstra HJ, Suurmeijer AJ. Diagnostic accuracy of FISH and RT-PCR in 50 routinely processed synovial sarcomas. Appl Immunohistochem Mol Morphol 2008 16 : 246 250.
65. Mori H, Nagata M, Nishijima N et al. Malignant pheochromocytoma in a young adult forming the structure simulating Homer Wright rosette: Differentiation from neuroblastoma on repeating fluorescence in situ hybridization. Pathol Int 2008 58 : 518 523.
66. Fu B, Luo M, Lakkur S, Lucito R, Iacobuzio-Donahue CA. Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma. Cancer Biol Ther 2008 7 : 1593 1601.
67. Suzuki M, Kageyama S, Shinmura K et al. Inverse relationship between the length of the EGFR CA repeat polymorphism in lung carcinoma and protein expression of EGFR in the carcinoma. J Surg Oncol 2008 98 : 457 461.
68. Cappuzzo F, Marchetti A, Skokan M et al. Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. J Clin Oncol 2009 27 : 1667 1674.
69. Okudela K, Suzuki M, Kageyama S et al. PIK3CA mutation and amplification in human lung cancer. Pathol Int 2007 57 : 664 671.
70. Kato N, Itoh H, Serizawa A, Hatanaka Y, Umemura S, Osamura Y. Evaluation of HER2 Gene Amplification in Invasive Breast Cancer Using a Dual-color Chromogenic In Situ Hybridization (Dual CISH). Pathol Int 2010 60 : 510 515.